Palvella Therapeutics, Inc. (NASDAQ:PVLA – Get Free Report) Director Christopher Kiritsy sold 313 shares of Palvella Therapeutics stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $157.00, for a total transaction of $49,141.00. Following the sale, the director directly owned 250 shares in the company, […]

First Tracks Biotherapeutics (NASDAQ:TRAX – Get Free Report) Director J. Anthony Ware sold 39,265 shares of the business’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $44.78, for a total transaction of $1,758,286.70. Following the transaction, the director owned 15,660 shares in the company, valued at […]

908 Devices Inc. (NASDAQ:MASS – Get Free Report) Director Christopher Brown sold 30,000 shares of the company’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $10.58, for a total transaction of $317,400.00. Following the completion of the sale, the director owned 775,559 shares in the company, […]

Southern First Bancshares, Inc. (NASDAQ:SFST – Get Free Report) Director Leighton Cubbage sold 400 shares of the company’s stock in a transaction on Monday, August 24th. The stock was sold at an average price of $63.00, for a total transaction of $25,200.00. Following the transaction, the director owned 49,515 shares of the company’s stock, valued […]

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) Director Adeoye Olukotun sold 2,000 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $86.96, for a total value of $173,920.00. Following the completion of the transaction, the director owned 31,600 shares in the company, […]